Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 93 (2) , 305-308
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effective Antiviral Treatment of Systemic Orthopoxvirus Disease: ST-246 Treatment of Prairie Dogs Infected with Monkeypox VirusJournal of Virology, 2011
- Evaluation of Therapeutic Interventions for Vaccinia Virus KeratitisThe Journal of Infectious Diseases, 2011
- Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of CongoProceedings of the National Academy of Sciences, 2010
- Identification of Wild-Derived Inbred Mouse Strains Highly Susceptible to Monkeypox Virus Infection for Use as Small Animal ModelsJournal of Virology, 2010
- A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virusJournal of General Virology, 2009
- Vaccinia Virus DNA Ligase Recruits Cellular Topoisomerase II to Sites of Viral Replication and AssemblyJournal of Virology, 2008
- Identification of Novel Antipoxviral Agents: Mitoxantrone Inhibits Vaccinia Virus Replication by Blocking Virion AssemblyJournal of Virology, 2007
- Synergistic Efficacy of the Combination of ST-246 with CMX001 against OrthopoxvirusesAntimicrobial Agents and Chemotherapy, 2007
- Obligatory Requirement for Antibody in Recovery from a Primary Poxvirus InfectionJournal of Virology, 2006
- Bis-basic-substituted polycyclic aromatic compounds. New class of antiviral agents. 5. Bis-basic ethers of anthraquinone and bisalkamine esters of anthraquinonedicarboxylic acidsJournal of Medicinal Chemistry, 1974